These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 26468004)
1. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells. Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004 [TBL] [Abstract][Full Text] [Related]
2. Toxicity of Mitoxantrone-loaded Superparamagnetic Iron Oxide Nanoparticles in a HT-29 Tumour Spheroid Model. Hornung A; Poettler M; Friedrich RP; Weigel B; Duerr S; Zaloga J; Cicha I; Alexiou C; Janko C Anticancer Res; 2016 Jun; 36(6):3093-101. PubMed ID: 27272833 [TBL] [Abstract][Full Text] [Related]
3. Treatment Efficiency of Free and Nanoparticle-Loaded Mitoxantrone for Magnetic Drug Targeting in Multicellular Tumor Spheroids. Hornung A; Poettler M; Friedrich RP; Zaloga J; Unterweger H; Lyer S; Nowak J; Odenbach S; Alexiou C; Janko C Molecules; 2015 Sep; 20(10):18016-30. PubMed ID: 26437393 [TBL] [Abstract][Full Text] [Related]
4. Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles. Zaloga J; Feoktystov A; Garamus VM; Karawacka W; Ioffe A; Brückel T; Tietze R; Alexiou C; Lyer S Colloids Surf B Biointerfaces; 2018 Jan; 161():18-26. PubMed ID: 29035747 [TBL] [Abstract][Full Text] [Related]
5. Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy. Guissi NE; Li H; Xu Y; Semcheddine F; Chen M; Su Z; Ping Q Mol Pharm; 2017 Apr; 14(4):1082-1094. PubMed ID: 28191959 [TBL] [Abstract][Full Text] [Related]
6. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake. Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541 [TBL] [Abstract][Full Text] [Related]
7. High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy. Peng N; Wu B; Wang L; He W; Ai Z; Zhang X; Wang Y; Fan L; Ye Q Biomater Sci; 2016 Nov; 4(12):1802-1813. PubMed ID: 27792228 [TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids. Dinter J; Friedrich RP; Yang H; Pilarsky C; Mangge H; Pöttler M; Janko C; Alexiou C; Lyer S Materials (Basel); 2023 Apr; 16(7):. PubMed ID: 37049199 [TBL] [Abstract][Full Text] [Related]
9. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent. Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545 [TBL] [Abstract][Full Text] [Related]
10. Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility. Zaloga J; Janko C; Nowak J; Matuszak J; Knaup S; Eberbeck D; Tietze R; Unterweger H; Friedrich RP; Duerr S; Heimke-Brinck R; Baum E; Cicha I; Dörje F; Odenbach S; Lyer S; Lee G; Alexiou C Int J Nanomedicine; 2014; 9():4847-66. PubMed ID: 25364244 [TBL] [Abstract][Full Text] [Related]
11. A superparamagnetic Fe3O4-loaded polymeric nanocarrier for targeted delivery of evodiamine with enhanced antitumor efficacy. Lv Y; Ding G; Zhai J; Guo Y; Nie G; Xu L Colloids Surf B Biointerfaces; 2013 Oct; 110():411-8. PubMed ID: 23759382 [TBL] [Abstract][Full Text] [Related]
12. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells. Pernal S; Wu VM; Uskoković V ACS Appl Mater Interfaces; 2017 Nov; 9(45):39283-39302. PubMed ID: 29058880 [TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Wahajuddin ; Arora S Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170 [TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics. Huang Y; Mao K; Zhang B; Zhao Y Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953 [TBL] [Abstract][Full Text] [Related]
15. Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties. He X; Wu X; Cai X; Lin S; Xie M; Zhu X; Yan D Langmuir; 2012 Aug; 28(32):11929-38. PubMed ID: 22799877 [TBL] [Abstract][Full Text] [Related]
16. Bioevaluation of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with dihexadecyl phosphate (DHP). Mieloch AA; Żurawek M; Giersig M; Rozwadowska N; Rybka JD Sci Rep; 2020 Feb; 10(1):2725. PubMed ID: 32066785 [TBL] [Abstract][Full Text] [Related]
17. Thermal and microwave synthesized SPIONs: Energy effects on the efficiency of nano drug carriers. Saxena N; Agraval H; Barick KC; Ray D; Aswal VK; Singh A; Yadav UCS; Dube CL Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110792. PubMed ID: 32279785 [TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux. Ling G; Zhang T; Zhang P; Sun J; He Z Drug Dev Ind Pharm; 2016 Aug; 42(8):1351-9. PubMed ID: 26754913 [TBL] [Abstract][Full Text] [Related]
19. Superparamagnetic Iron Oxide Nanoparticles Carrying Chemotherapeutics Improve Drug Efficacy in Monolayer and Spheroid Cell Culture by Enabling Active Accumulation. Nguyen K; Nuß B; Mühlberger M; Unterweger H; Friedrich RP; Alexiou C; Janko C Nanomaterials (Basel); 2020 Aug; 10(8):. PubMed ID: 32796757 [TBL] [Abstract][Full Text] [Related]
20. Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells. Lindemann A; Lüdtke-Buzug K; Fräderich BM; Gräfe K; Pries R; Wollenberg B Int J Nanomedicine; 2014; 9():5025-40. PubMed ID: 25378928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]